Advances in Cardiomyopathies

Proceedings of the II Florence Meeting on Advances on Cardiomyopathies April 24–26, 1997

Fulvio Camerini, Antonello Gavazzi, Renata DeMaria (Herausgeber)

Buch | Softcover

317 Seiten

2012 | Softcover reprint of the original 1st ed. 1998
Springer Verlag
978-88-470-2181-5 (ISBN)

Artikel merken

The Italian Study Group on Cardiomyopathies organized in Florence in April 1997, eight years after the first successful meeting, the second international symposium devoted to "Advances in Cardiomyopathies". In these years exceptional progress has been made in the field of heart muscle diseases, in clinical research as well as in molecular biology, molec- ular genetics., pathophysiology and treatment. Many of these advances were presented and discussed in Florence by a distinguished team of international experts. Hypertrophic cardiomyopathy was addressed in ten papers; in the first one Seidman reported the results obtained by the use of molecular genetic tech- niques which showed that hypertrophic cardiomyopathy is a heterogeneous disorder caused by different mutations of different genes and discussed the clinical role and significance of genetic testing. Original data regarding the natural history and prognosis of symptomatic patients were obtained in the Italian multicentric study (Cecchi, Lazzeroni), while Baroldi discussed the clinico-pathologic spectrum of the disease in severely symptomatic patients treated with heart transplantation.
Sudden death in the young (Basso), the identification and management of high risk patients (Elliott), the clinical importance and the problems of detec- tion of ischemia (Camici) were deeply discussed as well as the indications and results of different types of treatment: medical, surgical, DDD pacing (Spirito, Betocchi, Schoendube).

Introduction: II Florence Meeting on Advances in Cardiomyopathies.- The Classification of Cardiomyopathies.- Hypertrophic Cardiomyopathy.- The Clinical Significance of Genetic Testing in Familial Hypertrophic Cardiomyopathy.- The Italian Multicentric Study on Hypertrophic Cardiomyopathy: I. Natural History and Clinical Course of Unselected Patients.- The Italian Multicentric Study on Hypertrophic Cardiomyopathy: II. Prognostic Assessment in Symptomatic Patients.- Detection and Clinical Consequences of Myocardial Ischemia and Reduced Coronary Reserve.- Identification and Management of High Risk Patients with Hypertrophic Cardiomyopathy.- Hypertrophic Cardiomyopathy and Sudden Death in the Young: a Pathologist’s View.- The Clinicopathologic Spectrum of Hypertrophic Cardiomiopathy. The Experience of the Italian Heart Transplant Program.- Medical Treatment Options in Hypertrophic Cardiomyopathy.- DDD Pacing in Hypertrophic Cardiomyopathy: State of the Art.- Indications and Outcome of Cardiac Surgery for Severely Symptomatic Patients with Hypertrophic Obstructive Cardiomyopathy.- Dilated Cardiomyopathy: Etiology, Pathophysiology and Clinical Data.- Genetic Basis of Dilated Cardiomyopathy.- Virus Infection in Cardiomyopathies: Brief Overview, Recent Advances.- Organ-Specific Cardiac Autoantibodies in Dilated Cardiomyopathy: Pathogenetic Implications.- Inflammatory Cardiomyopathy: Diagnostic and Therapeutical Options.- Mitochondrial DNA Mutations and Cardiomyopathies.- Pathophysiologic Role of Coronary Microcirculatory Impairment in Dilated Cardiomyopathy.- Myocardial Catecholamines and Inotropic Response in Heart Muscle Disease.- Molecular Biology of Heart Failure.- Dilated Cardiomyopathy: Does Etiological Heterogeneity Portend Clinical Heterogeneity?.- Recent Advances in Etiopathogenesis of Dilated Cardiomyopathy: Which Relevance for the Clinical Cardiologist?.- The Italian Multicentric Study: Natural History of Dilated Cardiomyopathy.- Mildly Dilated Cardiomyopathy.- Dilated Cardiomyopathy: Treatment.- Immunosuppressive Treatment for Inflammatory Dilated Cardiomyopathy (Myocarditis).- Prevention of Sudden Death in Patients with Dilated Cardiomyopathy.- Medical Treatment of Heart Failure: Problems in Dilated Cardiomyopathy.- Treatment of Dilated Cardiomyopathies with ?-adrenergic Blocking Agents.- The role of ?-Blockers in the Management of Heart Failure: Results of Controlled Trials.- Controversial Issues on ?-Blocker Treatment: Has Metoprolol an Additive Effect to Conventional Medical Treatment in Heart Failure Due to Dilated Cardiomyopathy?.- ?-Blockers for Heart Failure: Practical Issues.- DDD Pacing in Dilated Cardiomyopathy.- End-Stage Heart Failure and Timing of Heart Transplantation.- Cardiomyoplasty: Surgical Therapy for Ischemic and Idiopathic Dilated Cardiomyopathies.- Left Ventricular Assist Device as Bridge to Transplantation.

Zusatzinfo	15 Illustrations, color; 45 Illustrations, black and white; XV, 317 p. 60 illus., 15 illus. in color.
Verlagsort	Milan
Sprache	englisch
Maße	170 x 244 mm
Themenwelt	Medizinische Fachgebiete ► Innere Medizin ► Kardiologie / Angiologie
Themenwelt	Studium ► 2. Studienabschnitt (Klinik) ► Pathologie
Schlagworte	Dilated cardiomyopathy • familial cardiomyopathies • hypertrophic cardiomyopathie • medical treatment
ISBN-10	88-470-2181-2 / 8847021812
ISBN-13	978-88-470-2181-5 / 9788847021815
Zustand	Neuware